CTX-8371

· Compass Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTX-8371, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 of CTX-8371 in Patients With Advanced Malignancies [Phase 1]